 Connection
Douglas Fish to Anti-Infective Agents
This is a "connection" page, showing publications Douglas Fish has written about Anti-Infective Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.386 |
|
|
|
-
Fish DN. Evaluation of gatifloxacin pharmacokinetics and pharmacodynamics in severely ill adults in a medical Intensive Care Unit. Int J Antimicrob Agents. 2007 Jun; 29(6):715-23.
Score: 0.238
-
Jung R, Husain M, Choi MK, Fish DN. Synergistic activities of moxifloxacin combined with piperacillin-tazobactam or cefepime against Klebsiella pneumoniae, Enterobacter cloacae, and Acinetobacter baumannii clinical isolates. Antimicrob Agents Chemother. 2004 Mar; 48(3):1055-7.
Score: 0.192
-
Fish DN. Bronchoscopic sampling of drug concentrations: penetration to tissue is the issue. Am J Respir Crit Care Med. 2003 Dec 01; 168(11):1263-5.
Score: 0.188
-
Rudis MI, Fish DN. Pharmacology, clinical efficacy, and safety of drotrecogin alfa (activated). Pharmacotherapy. 2002 Dec; 22(12 Pt 2):182S-195S.
Score: 0.176
-
Fish DN. Optimal antimicrobial therapy for sepsis. Am J Health Syst Pharm. 2002 Feb 15; 59 Suppl 1:S13-9.
Score: 0.166
-
Fish DN. Fluoroquinolone adverse effects and drug interactions. Pharmacotherapy. 2001 Oct; 21(10 Pt 2):253S-272S.
Score: 0.162
-
Fish DN, North DS. Gatifloxacin, an advanced 8-methoxy fluoroquinolone. Pharmacotherapy. 2001 Jan; 21(1):35-59.
Score: 0.154
-
Bertino J, Fish D. The safety profile of the fluoroquinolones. Clin Ther. 2000 Jul; 22(7):798-817; discussion 797.
Score: 0.149
-
Olsen KM, Rebuck JA, Weidenbach T, Fish DN. Pharmacokinetics of intravenous trovafloxacin in critically ill adults. Pharmacotherapy. 2000 Apr; 20(4):400-4.
Score: 0.146
-
Fish DN. Nonsurgical antimicrobial prophylaxis: guidelines (and bugs) in evolution. Am J Health Syst Pharm. 1999 Jun 15; 56(12):1199.
Score: 0.138
-
Lee LJ, Sha X, Gotfried MH, Howard JR, Dix RK, Fish DN. Penetration of levofloxacin into lung tissue after oral administration to subjects undergoing lung biopsy or lobectomy. Pharmacotherapy. 1998 Jan-Feb; 18(1):35-41.
Score: 0.125
-
Fish DN, Chow AT. The clinical pharmacokinetics of levofloxacin. Clin Pharmacokinet. 1997 Feb; 32(2):101-19.
Score: 0.117
-
Li PK, Szeto CC, Piraino B, de Arteaga J, Fan S, Figueiredo AE, Fish DN, Goffin E, Kim YL, Salzer W, Struijk DG, Teitelbaum I, Johnson DW. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit Dial Int. 2016 09 10; 36(5):481-508.
Score: 0.112
-
Bratzler DW, Dellinger EP, Olsen KM, Perl TM, Auwaerter PG, Bolon MK, Fish DN, Napolitano LM, Sawyer RG, Slain D, Steinberg JP, Weinstein RA. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Surg Infect (Larchmt). 2013 Feb; 14(1):73-156.
Score: 0.089
-
Fish DN, Rodvold KA. Fluoroquinolone treatment of Enterococcus infection. Ann Pharmacother. 1992 Apr; 26(4):498-500.
Score: 0.084
-
Jung R, Fish DN, Obritsch MD, MacLaren R. Surveillance of multi-drug resistant Pseudomonas aeruginosa in an urban tertiary-care teaching hospital. J Hosp Infect. 2004 Jun; 57(2):105-11.
Score: 0.049
-
Malone RS, Fish DN, Abraham E, Teitelbaum I. Pharmacokinetics of levofloxacin and ciprofloxacin during continuous renal replacement therapy in critically ill patients. Antimicrob Agents Chemother. 2001 Oct; 45(10):2949-54.
Score: 0.041
-
North DS, Fish DN, Redington JJ. Levofloxacin, a second-generation fluoroquinolone. Pharmacotherapy. 1998 Sep-Oct; 18(5):915-35.
Score: 0.033
-
Fish DN, Piscitelli SC, Danziger LH. Development of resistance during antimicrobial therapy: a review of antibiotic classes and patient characteristics in 173 studies. Pharmacotherapy. 1995 May-Jun; 15(3):279-91.
Score: 0.026
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|